Naldemedine Tosylate | m-entrepreneurship.com

Product Name :
Naldemedine Tosylate

Search keywords :
Naldemedine

drugId :
null

Target Vo:
Mu opioid receptor

Target Vo Short Name :
MOR1

Moa_Name:
Mu opioid receptor antagonists

First Approval Country :
United States

First Approval Date Filter:
2017

Origin Company_Name :
Shionogi & Co Ltd

Active Company_Name :
Bdsi

Active Indication_Name:
Opioid-Induced Constipation

In Active Indication_Name:
Gastrointestinal Diseases

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Phase 3 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
MyD88 Rabbit mAb In Vitro
SIRT2 Rabbit mAb manufacturer
DDB1 Antibody (YA785): DDB1 Antibody (YA785) is a non-conjugated and Mouse origined monoclonal antibody about 127 kDa, targeting to DDB1 (2D6). It can be used for WB assays with tag free, in the background of Human, Mouse, Rat, Monkey.

Author: Betaine hydrochloride

Related Posts